Tag: Venous disease

AVF 2024: Outgoing president addresses history, future direction of American Venous...

At the 2024 American Venous Forum (AVF) in Tampa, Florida (March 3–6), Glenn Jacobowitz, MD, professor of vascular and endovascular surgery at NYU Langone...

Non-pneumatic compression device performed better than advanced pneumatic compression for lower...

A new study presented during the 2024 American Venous Forum (AVF) in Tampa, Florida (March 3–6), that compared a novel non-pneumatic compression device with...

New Florida vascular chief sets vision aimed at improving outcomes through...

This advertorial is sponsored by Tampa General Hospital. Early on, Jean Bismuth, MD, acquired a passion for vascular surgery from a world-class source. Back in...

Enrollment complete in APEX-AV study of mechanical aspiration system for acute...

Patient enrollment is now complete in the APEX-AV trial evaluating the safety and efficacy of the AlphaVac F1885 (AngioDynamics) multipurpose mechanical aspiration system for...

Vascular Specialist–December 2023

In this issue: Changing course: The natural history of tibial claudication comes under scrutiny as interventions for "relatively benign" disease trend upward  Our guest editorial...

Computer-assisted vacuum thrombectomy system for patients with pulmonary embolism demonstrates ‘rapid,...

Patients undergoing computer-assisted vacuum thrombectomy with the Indigo Aspiration System (Penumbra) for pulmonary embolism (PE) showed 2.7% rates of both major adverse events (MAEs)...

Survey suggests venous work less valued than arterial interventions

The majority of more than 300 vascular surgeons who responded to a recent survey indicated that they perceive the management of venous disease to...

NESVS 2023: Novel IVC filter retrieval device slashes procedural time and...

An inferior vena cava (IVC) filter retrieval device dubbed the next-generation in removal of the venous thromboembolism-fighting tools could substantially cut procedural times and...

SVS varicose vein guideline webinar set for Oct. 10

A virtual roundtable on Oct. 10 will cover the new Society for Vascular Surgery (SVS) varicose veins guidelines. Set for 6–7:30 p.m. CDT, the...

EVS 2023: New data chart underrepresentation of women at the head...

The underrepresentation of women vascular surgeons in national clinical trial leadership formed the central theme of data coming out of a new study that...

Submit ideas for VAM 2024 educational sessions

Organizers of VAM 2024 want members to consider what the modern-day vascular surgeon needs to know for optimal patient care and professional success. What’s...

Venous stenting and the IVC: ‘Persistent problems’ in the setting of...

The question of “persistent problems” with venous stenting among post-thrombotic syndrome (PTS) patients emerged as a key talking point during the recent Deep Venous...

Review urges development of protocols to reduce hypersensitivity reactions after cyanoacrylate...

Despite being considered “generally safe,” cyanoacrylate can cause local reactions in up to 25% of patients, disproportionately affecting women, Asian race and thin patients...

Cook Medical treats first patient in first-in-human clinical trial for venous...

Cook Medical recently announced that the first patient has been treated in a clinical study to evaluate a new venous valve designed for treating...

FDA approves IDE for pivotal study of high-intensity focused ultrasound platform

The Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application for the VEINRESET multicenter pivotal study that will evaluate Sonovein...
VAM

Trainees: Cases sought for three VAM sessions   

Vascular trainees and medical students are invited to submit their best cases for three sessions at the Society for Vascular Surgery (SVS) Vascular Annual...

Bioprosthetic venous valve: ‘We want to know that this is really...

A key investigator in efforts to tackle chronic venous insufficiency (CVI) with an bioprosthetic venous valve replacement talks about progress being made with surgical...

ABCs for the treatment of lower-extremity acute DVTs

Ashish Gupta, MD, outlines his ABCs for confronting and treating patients with acute deep vein thrombosis (DVT) of the lower extremity, and how he...

Venous stenting: ‘We need to evaluate use, appropriateness and clinical indication’

An analysis of venous stent usage trends in the United States from 2014 through 2021 showed a “significant increase” in stents per day placed...

AVF 2023: Investigators report update on three-year first-in-human results for bioprosthetic...

Researchers in Colombia behind the first-in-human study of a novel bioprosthetic venous valve designed to treat chronic venous insufficiency (CVI) reported three-year results among...

Vascular Specialist–February 2023

In this issue: Educate, and educate, and educate again: The continuing quest for appropriate venous care (p. 1 and 6) Likes, dislikes and reposts:...

First patient enrolled in DEFIANCE trial of the ClotTriever system in...

Inari Medical announced that the first patient has been enrolled in DEFIANCE, a prospective randomized controlled trial (RCT) comparing the clinical outcomes of patients...

VESAP5: Now up to 25% off

With the expiration of the fifth edition of the Vascular Education and Self-Assessment Program (VESAP5) in July, the Society for Vascular Surgery (SVS) is...

High-risk venous stasis ulceration patients show similar healing rates after multi-modal...

A single-center evaluation of contemporary, multi-modal surgical therapy for venous stasis ulceration (C6 disease) suggests high-risk patients showed similar healing rates at one year,...
DVT

Meta-analysis of PTS finds one in five at risk of long-term...

A meta-analysis is first to report the pooled risk of post-thrombotic syndrome (PTS) after isolated distal deep vein thrombosis (DVT). Researchers revealed a one-in-five...

SVS reveals research priorities for next decade

The Society for Vascular Surgery (SVS) Research Council has updated its top 10 research priorities, originally published in 2011, with patient-centered outcomes and personalized...

Roundtable on varicose veins guidelines set for Dec. 6

A virtual, multidisciplinary and interactive roundtable discussion on varicose veins will be held Dec. 6. The free roundtable, set for 6 to 7:30 p.m. CST,...

ABRE clinical study 36-month data show ‘long-term durability’ of venous stent...

Medtronic has announced the 36-month final results from the ABRE clinical study. The purpose of the ABRE clinical study was to evaluate the safety and...

New study indicates cost-effectiveness of Denali IVC filter over Option device

Tilting or hooking occurred significantly less often in the process of retrieving the Denali inferior vena cava (IVC) filter than with the Option IVC...

Clinical outcomes of the ClotTriever system in DVT set to be...

Inari Medical has announced planned enrollment of the DEFIANCE randomized controlled trial (RCT), which is designed to compare the clinical outcomes of patients with...

Retrospective study is ‘first to systematically explore predictors of venous stent...

New data indicate that venous stent failure “may be predicted by low peak flow velocity and post-thrombotic changes in inflow veins” and that endovascular venous...

Key differences in presentation, outcomes for distal versus proximal DVT uncovered

A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep...

Venovo venous stent returns to US market after 2021 recall

BD recently announced that its Venovo venous stent is back on the U.S. market following a recall last year. In 2019, the company reported that the...
top 10 vascular specialist

The top 10 most popular Vascular Specialist stories in April 2022

The digital version of the April 2022 issue of Vascular Specialist, the most recent editorial by our medical editor focusing on diversity within the...

CX 2022: Overtreatment in venous disease: Financial incentives are ‘the elephant...

To combat the “overtreatment problem” in the appropriate care of venous disease, “a concerted, complex, multimodal effort” is required from specialists across disparate parts...

Select gene SNPs found to be associated with venous ulcer formation...

Looking to the future, genetic testing may play a role in guiding the intensity of therapeutic interventions and preventive strategies in patients with venous...

New JVS editorial leadership structure announced

The Executive Board of the Society for Vascular Surgery (SVS) recently revealed the new composition of the Journal of Vascular Surgery (JVS) publications‘ senior...

Venous stents remain durable following pregnancy, researchers find

Iliac vein stents tolerate a gravid uterus well and a possible future pregnancy should not contraindicate their usage in the treatment of pelvic venous...

AVF 2022: Emerging autogenous venous valve formation system sees ‘continual improvement’

An emerging endovenous valve formation system designed to treat patients with chronic venous insufficiency (CVI) with evidence of deep venous reflux has demonstrated continual...

AVF 2022: VenoValve improvement ‘maintained’ for 2.5 years without adverse events

Envveno Medical announced positive 30-month data from the first-in-human trial of the VenoValve bioprosthetic potential venous valve replacement during the 2022 American Venous Forum (AVF)...

Risk of venous stent migration ‘rare’ but probably ‘underreported,’ systematic review...

Stent migration following treatment of acute iliofemoral thrombus or venous obstruction is “rare but may be underreported,” with the majority of reported cases being...

Office-based laboratory setting proves ‘safe’ for iliac vein stenting

A retrospective study of 1,223 iliac vein cases performed in three office-based laboratories (OBLs) demonstrated a major complication rate of 0.41%, suggesting these procedures...

Thrombolex: Investigational RESCUE trial yields ‘exciting’ interim data

The prespecified interim analysis of the first 62 evaluable pulmonary embolism (PE) patients enrolled in the investigational RESCUE trial produced positive results, Thrombolex has...

Europe: ESVS publishes 2022 guidelines on management of chronic venous disease...

The European Society for Vascular Surgery (ESVS) has released 2022 clinical practice guidelines on the management of chronic venous disease (CVD) of the lower...

VIVID study on Duo venous stent system now fully enrolled, Vesper...

Vesper Medical recently announced the completion of enrollment in its pivotal study—VIVID (Venous stent for the iliofemoral vein investigational clinical trial using the Vesper Duo venous stent...

FDA approves two pediatric venous thromboembolism indications for rivaroxaban

The Food and Drug Administration (FDA) has approved two pediatric indications for Xarelto (rivaroxaban): the treatment of venous thromboembolism (VTE) and reduction in the risk of recurrent...

Venous disease: SVS DEI Committee seeks survey participants

The Society for Vascular Surgery (SVS) Diversity, Equity and Inclusion (DEI) Committee is calling on vascular surgeons to complete a survey focused on patterns...

Study: Early thrombosis after iliac stenting for venous outflow occlusion is...

Fewer than 10 days of low-molecular-weight heparin (LMWH) after stenting for extensive iliofemoral venous occlusion prior to transition to oral anticoagulation reduces early thrombosis,...

Three-year VIVO results back ‘continued safety and effectiveness’ of Zilver Vena...

Three-year results of the VIVO clinical study support the continued safety and effectiveness of the Zilver Vena venous stent (Cook Medical) in the treatment of symptomatic...

Registry data show greater clot chronicity on post-procedure inspection than initially...

Nearly half of patients deemed pre-procedurally to be suffering an acute case of deep vein thrombosis (DVT) turned out to have a “much more”...
top 10

The top 10 most popular Vascular Specialist stories in August

Our recent editorial on the status of the interview, one of the Presidential Addresses from the Vascular Annual Meeting (VAM), a slew of new...

‘The future is very bright for venous valve replacement’

The progress of two “promising” new devices in the venous valve replacement space were outlined during a Vascular Annual Meeting (VAM) special session co-hosted...

Study shows increase in risk of renal failure following lytic therapy...

A large, single-centre retrospective study has revealed the risk of acute kidney injury (AKI) following pharmacomechanical thrombolysis (PMT) for lower-extremity deep vein thrombosis (DVT)...

Boston Scientific and BD initiate venous stent recalls

Boston Scientific and BD have both initiated recalls of venous stents. According to a Food and Drug Administration (FDA) medical device recall notice posted...

The top 10 most popular stories from April

Our April cover story on the links between electronic health records (EHRs) and physician burnout, the continuing problem of manels (or all-male speaking panels)...

New data support ‘routine’ use of IVUS during iliac vein stenting...

A recent study on iliac vein stenting showed better short and mid-term patency rates when intravascular ultrasound (IVUS) was utilized prior to stent deployment...

Researchers recommend national registries address geographical variation in DVT guideline implementation

A new review concludes that the implementation of clinical guidelines for the management of patients with deep vein thrombosis (DVT) varies among countries, from strict...

Study: ELVeS Radial varicose vein laser therapy shows ‘excellent’ long-term results

Long-term results of patients who underwent outpatient laser treatment for varicose veins at the great saphenous vein (GSV) or small saphenous vein (SSV) in...

Vesper Medical announces first enrollment in the VIVID trial

Vesper Medical recently announced initiation of its Food and Drug Administration (FDA) investigational device exemption (IDE) study, VIVID (Venous stent for the iliofemoral vein investigational clinical trial...

AVF schedules education series for trainees, early-career practitioners

The American Venous Forum (AVF) is to stage a four-part series of educational sessions running the gamut of venous disorders aimed at residents, fellows...

Women are at a higher risk of iliac vein stent failure,...

A recent study on iliac vein stenting showed lower long-term patency rates for women when compared to their male counterparts. The data were presented...

Dispatches from the vascular front: A vascular nursing perspective in times...

For almost the first month after COVID-19 hit New Orleans with a vengeance, vascular nurse Jayme Boudreaux, APRN, found herself largely stuck at home,...

Elder statesman of venous disease delivers golfing metaphor for fortitude, wellness

AMELIA ISLAND, Fla.—As a podium talk at the annual meeting of the American Venous Forum (AVF), it represented a bit of an outlier. It...